Adult  ||| S:0 E:6 ||| NN
neurogenesis  ||| S:6 E:19 ||| NNS
and  ||| S:19 E:23 ||| CC
depression ||| S:23 E:33 ||| NN
:  ||| S:33 E:35 ||| :
an  ||| S:35 E:38 ||| DT
introduction  ||| S:38 E:51 ||| NN
The  ||| S:51 E:55 ||| DT
following  ||| S:55 E:65 ||| JJ
essay  ||| S:65 E:71 ||| NN
provides  ||| S:71 E:80 ||| VBZ
a  ||| S:80 E:82 ||| DT
summary  ||| S:82 E:90 ||| NN
of  ||| S:90 E:93 ||| IN
a  ||| S:93 E:95 ||| DT
seminar  ||| S:95 E:103 ||| NN
given  ||| S:103 E:109 ||| VBN
on  ||| S:109 E:112 ||| IN
the  ||| S:112 E:116 ||| DT
sixth  ||| S:116 E:122 ||| JJ
of  ||| S:122 E:125 ||| IN
November ||| S:125 E:133 ||| NNP
,  ||| S:133 E:135 ||| ,
2010  ||| S:135 E:140 ||| CD
at  ||| S:140 E:143 ||| IN
the  ||| S:143 E:147 ||| DT
combined  ||| S:147 E:156 ||| JJ
annual  ||| S:156 E:163 ||| JJ
congress ||| S:163 E:171 ||| NN
,  ||| S:171 E:173 ||| ,
held  ||| S:173 E:178 ||| VBN
at  ||| S:178 E:181 ||| IN
Brussels  ||| S:181 E:190 ||| NNP
of  ||| S:190 E:193 ||| IN
the  ||| S:193 E:197 ||| DT
Centro  ||| S:197 E:204 ||| NNP
Studi  ||| S:204 E:210 ||| NNP
Psichatrici  ||| S:210 E:222 ||| NNP
Vrije  ||| S:222 E:228 ||| NNP
Universiteit  ||| S:228 E:241 ||| NNP
Brussel ||| S:241 E:248 ||| NNP
,  ||| S:248 E:250 ||| ,
Universit√©  ||| S:250 E:261 ||| NNP
Catholique  ||| S:261 E:272 ||| NNP
de  ||| S:272 E:275 ||| NNP
Louvain  ||| S:275 E:283 ||| NNP
&  ||| S:283 E:285 ||| CC
the  ||| S:285 E:289 ||| DT
Bedfordshire  ||| S:289 E:302 ||| NNP
Centre  ||| S:302 E:309 ||| NNP
for  ||| S:309 E:313 ||| IN
Mental  ||| S:313 E:320 ||| NNP
Health  ||| S:320 E:327 ||| NNP
Research ||| S:327 E:335 ||| NNP
.  ||| S:335 E:337 ||| .
The  ||| S:337 E:341 ||| DT
talk  ||| S:341 E:346 ||| NN
aimed  ||| S:346 E:352 ||| VBN
to  ||| S:352 E:355 ||| TO
present  ||| S:355 E:363 ||| VB
a  ||| S:363 E:365 ||| DT
brief  ||| S:365 E:371 ||| JJ
taster ||| S:371 E:377 ||| NN
,  ||| S:377 E:379 ||| ,
assuming  ||| S:379 E:388 ||| VBG
no  ||| S:388 E:391 ||| DT
prior  ||| S:391 E:397 ||| JJ
knowledge ||| S:397 E:406 ||| NN
,  ||| S:406 E:408 ||| ,
of  ||| S:408 E:411 ||| IN
adult  ||| S:411 E:417 ||| NN
neurogenesis ||| S:417 E:429 ||| NN
,  ||| S:429 E:431 ||| ,
the  ||| S:431 E:435 ||| DT
formation  ||| S:435 E:445 ||| NN
of  ||| S:445 E:448 ||| IN
new  ||| S:448 E:452 ||| JJ
nerve  ||| S:452 E:458 ||| NN
cells ||| S:458 E:463 ||| NNS
,  ||| S:463 E:465 ||| ,
in  ||| S:465 E:468 ||| IN
relation  ||| S:468 E:477 ||| NN
to  ||| S:477 E:480 ||| TO
the  ||| S:480 E:484 ||| DT
aetiology  ||| S:484 E:494 ||| NN
and  ||| S:494 E:498 ||| CC
treatment  ||| S:498 E:508 ||| NN
of  ||| S:508 E:511 ||| IN
depression ||| S:511 E:521 ||| NN
.  ||| S:521 E:523 ||| .
The  ||| S:523 E:527 ||| DT
talk  ||| S:527 E:532 ||| NN
begins  ||| S:532 E:539 ||| VBZ
with  ||| S:539 E:544 ||| IN
an  ||| S:544 E:547 ||| DT
introduction  ||| S:547 E:560 ||| NN
to  ||| S:560 E:563 ||| TO
the  ||| S:563 E:567 ||| DT
principles  ||| S:567 E:578 ||| NNS
of  ||| S:578 E:581 ||| IN
adult  ||| S:581 E:587 ||| NN
neurogenesis ||| S:587 E:599 ||| NNS
:  ||| S:599 E:601 ||| :
from  ||| S:601 E:606 ||| IN
initial  ||| S:606 E:614 ||| JJ
investigations  ||| S:614 E:629 ||| NNS
by  ||| S:629 E:632 ||| IN
Ramon  ||| S:632 E:638 ||| NNP
y  ||| S:638 E:640 ||| VBD
Cajal  ||| S:640 E:646 ||| NNP
in  ||| S:646 E:649 ||| IN
the  ||| S:649 E:653 ||| DT
19th  ||| S:653 E:658 ||| JJ
century ||| S:658 E:665 ||| NN
,  ||| S:665 E:667 ||| ,
resulting  ||| S:667 E:677 ||| VBG
in  ||| S:677 E:680 ||| IN
a  ||| S:680 E:682 ||| DT
static  ||| S:682 E:689 ||| JJ
brain  ||| S:689 E:695 ||| NN
hypothesis ||| S:695 E:705 ||| NN
,  ||| S:705 E:707 ||| ,
to  ||| S:707 E:710 ||| TO
their  ||| S:710 E:716 ||| PRP$
subsequent  ||| S:716 E:727 ||| JJ
challenge  ||| S:727 E:737 ||| NN
almost  ||| S:737 E:744 ||| RB
one  ||| S:744 E:748 ||| CD
hundred  ||| S:748 E:756 ||| CD
years  ||| S:756 E:762 ||| NNS
later ||| S:762 E:767 ||| RB
.  ||| S:767 E:769 ||| .
The  ||| S:769 E:773 ||| DT
potential  ||| S:773 E:783 ||| JJ
functional  ||| S:783 E:794 ||| JJ
implications  ||| S:794 E:807 ||| NNS
emerging ||| S:807 E:815 ||| VBG
,  ||| S:815 E:817 ||| ,
especially  ||| S:817 E:828 ||| RB
in  ||| S:828 E:831 ||| IN
relation  ||| S:831 E:840 ||| NN
to  ||| S:840 E:843 ||| TO
depression ||| S:843 E:853 ||| NN
,  ||| S:853 E:855 ||| ,
are  ||| S:855 E:859 ||| VBP
explored ||| S:859 E:867 ||| VBN
.  ||| S:867 E:869 ||| .
The  ||| S:869 E:873 ||| DT
fascinating  ||| S:873 E:885 ||| JJ
effects  ||| S:885 E:893 ||| NNS
of  ||| S:893 E:896 ||| IN
corticosteroids  ||| S:896 E:912 ||| NN
and  ||| S:912 E:916 ||| CC
antidepressants  ||| S:916 E:932 ||| NNS
are  ||| S:932 E:936 ||| VBP
used  ||| S:936 E:941 ||| VBN
as  ||| S:941 E:944 ||| IN
examples  ||| S:944 E:953 ||| NNS
to  ||| S:953 E:956 ||| TO
explore  ||| S:956 E:964 ||| VB
the  ||| S:964 E:968 ||| DT
possible  ||| S:968 E:977 ||| JJ
roles  ||| S:977 E:983 ||| NNS
of  ||| S:983 E:986 ||| IN
neurogenesis  ||| S:986 E:999 ||| NNS
that  ||| S:999 E:1004 ||| WDT
have  ||| S:1004 E:1009 ||| VBP
led  ||| S:1009 E:1013 ||| VBN
some  ||| S:1013 E:1018 ||| RB
to  ||| S:1018 E:1021 ||| TO
propose  ||| S:1021 E:1029 ||| VB
a  ||| S:1029 E:1031 ||| DT
neurogenic  ||| S:1031 E:1042 ||| JJ
theory  ||| S:1042 E:1049 ||| NN
of  ||| S:1049 E:1052 ||| IN
depression ||| S:1052 E:1062 ||| NN
.  ||| S:1062 E:1064 ||| .
Arguments  ||| S:1064 E:1074 ||| NNS
against  ||| S:1074 E:1082 ||| IN
this  ||| S:1082 E:1087 ||| DT
theory  ||| S:1087 E:1094 ||| NN
are  ||| S:1094 E:1098 ||| VBP
then  ||| S:1098 E:1103 ||| RB
presented ||| S:1103 E:1112 ||| VBN
.  ||| S:1112 E:1114 ||| .
Finally ||| S:1114 E:1121 ||| RB
,  ||| S:1121 E:1123 ||| ,
a  ||| S:1123 E:1125 ||| DT
consideration  ||| S:1125 E:1139 ||| NN
of  ||| S:1139 E:1142 ||| IN
future  ||| S:1142 E:1149 ||| JJ
opinion ||| S:1149 E:1156 ||| NN
:  ||| S:1156 E:1158 ||| :
could  ||| S:1158 E:1164 ||| MD
neurogenesis  ||| S:1164 E:1177 ||| RB
be  ||| S:1177 E:1180 ||| VB
less  ||| S:1180 E:1185 ||| RBR
important  ||| S:1185 E:1195 ||| JJ
in  ||| S:1195 E:1198 ||| IN
the  ||| S:1198 E:1202 ||| DT
aetiology  ||| S:1202 E:1212 ||| NN
of  ||| S:1212 E:1215 ||| IN
depression ||| S:1215 E:1225 ||| NN
,  ||| S:1225 E:1227 ||| ,
but  ||| S:1227 E:1231 ||| CC
involved  ||| S:1231 E:1240 ||| VBN
in  ||| S:1240 E:1243 ||| IN
its  ||| S:1243 E:1247 ||| PRP$
treatment  ||| S:1247 E:1257 ||| NN
-  ||| S:1257 E:1259 ||| :
a  ||| S:1259 E:1261 ||| DT
property  ||| S:1261 E:1270 ||| NN
of  ||| S:1270 E:1273 ||| IN
antidepressant  ||| S:1273 E:1288 ||| JJ
action  ||| S:1288 E:1295 ||| NN
rather  ||| S:1295 E:1302 ||| RB
than  ||| S:1302 E:1307 ||| IN
a  ||| S:1307 E:1309 ||| DT
central  ||| S:1309 E:1317 ||| JJ
final  ||| S:1317 E:1323 ||| JJ
aetiological  ||| S:1323 E:1336 ||| JJ
pathway ||| S:1336 E:1343 ||| NN
.  ||| S:1343 E:1345 ||| .
In  ||| S:1345 E:1348 ||| IN
this  ||| S:1348 E:1353 ||| DT
young  ||| S:1353 E:1359 ||| JJ
branch  ||| S:1359 E:1366 ||| NN
of  ||| S:1366 E:1369 ||| IN
neuroscience  ||| S:1369 E:1382 ||| JJ
controversy  ||| S:1382 E:1394 ||| NN
abounds ||| S:1394 E:1401 ||| NNS
:  ||| S:1401 E:1403 ||| :
our  ||| S:1403 E:1407 ||| PRP$
understanding  ||| S:1407 E:1421 ||| NN
of  ||| S:1421 E:1424 ||| IN
the  ||| S:1424 E:1428 ||| DT
process  ||| S:1428 E:1436 ||| NN
itself ||| S:1436 E:1442 ||| PRP
,  ||| S:1442 E:1444 ||| ,
its  ||| S:1444 E:1448 ||| PRP$
relations  ||| S:1448 E:1458 ||| NNS
and  ||| S:1458 E:1462 ||| CC
most  ||| S:1462 E:1467 ||| RBS
importantly  ||| S:1467 E:1479 ||| RB
its  ||| S:1479 E:1483 ||| PRP$
implications  ||| S:1483 E:1496 ||| NNS
are  ||| S:1496 E:1500 ||| VBP
all  ||| S:1500 E:1504 ||| RB
in  ||| S:1504 E:1507 ||| IN
their  ||| S:1507 E:1513 ||| PRP$
infancy ||| S:1513 E:1520 ||| NN
.  ||| S:1520 E:1522 ||| .
This  ||| S:1522 E:1527 ||| DT
has  ||| S:1527 E:1531 ||| VBZ
allowed  ||| S:1531 E:1539 ||| VBN
for  ||| S:1539 E:1543 ||| IN
some  ||| S:1543 E:1548 ||| DT
of  ||| S:1548 E:1551 ||| IN
the  ||| S:1551 E:1555 ||| DT
most  ||| S:1555 E:1560 ||| RBS
interesting  ||| S:1560 E:1572 ||| JJ
debate  ||| S:1572 E:1579 ||| NN
of  ||| S:1579 E:1582 ||| IN
recent  ||| S:1582 E:1589 ||| JJ
years  ||| S:1589 E:1595 ||| NNS
as  ||| S:1595 E:1598 ||| RB
to  ||| S:1598 E:1601 ||| TO
the  ||| S:1601 E:1605 ||| DT
neurological  ||| S:1605 E:1618 ||| JJ
basis  ||| S:1618 E:1624 ||| NN
and  ||| S:1624 E:1628 ||| CC
treatment  ||| S:1628 E:1638 ||| NN
of  ||| S:1638 E:1641 ||| IN
affective  ||| S:1641 E:1651 ||| JJ
disorders ||| S:1651 E:1660 ||| NNS
.  ||| S:1660 E:1662 ||| .
